Long-Term Trends in Antimicrobial Resistance Among Gram-Negative Clinical Isolates at Mubarak Al-Kabeer Hospital, Kuwait (2007–2022)

Objectives: To examine the long-term trends in antimicrobial resistance (AMR) among major Gram-negative pathogens including Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa collected from inpatient and outpatient specimens in Mubarak Al-Kabeer Hospital in Kuwait from 2007 to 2022. Methods: The antimicrobial resistance data for 39,200 non-duplicate Gram-negative isolates were collected from the Hospital Laboratory Information System (LIS). Retrospectively antibiotic susceptibility data were interpreted according to Clinical and Laboratory Standards Institute (CLSI) breakpoints with intermediate results classified as resistant. Logistic regression was applied to assess temporal trends in resistance for the following antibiotic cefotaxime, ceftazidime, ciprofloxacin, meropenem and imipenem. False discovery rate (FDR) correction was performed for multiple comparisons. Results: Third-generation cephalosporin resistance increased significantly, from 27% to 60% in Klebsiella pneumoniae and from 19% to 45% in Escherichia coli. Resistance to ciprofloxacin also increased, from 22% to 49% in K. pneumoniae and from 28% to 41% in E. coli. Notably, meropenem resistance in K. pneumoniae increased from 1% to 35% during the study period. Acinetobacter baumannii showed high resistance to most antibiotics (>75%), while colistin retained good activity (<2% resistance). By contrast, Pseudomonas aeruginosa showed relatively stable resistance patterns with only modest changes in susceptibility to key antibiotics. Conclusions: From 2007 to 2022, increasing resistance among major Gram-negative pathogens was observed, with cefotaxime resistance rising from 27% in 2007 to 60% in 2022 in Klebsiella pneumoniae and from 19% to 45% in Escherichia coli. Resistance to ciprofloxacin also increased over time. These findings highlight the increasing burden of antimicrobial resistance over time and emphasize the need for continued surveillance.

Institutions

Publication Details

Journal
Antibiotics
Published
2026-05-17
DOI
https://doi.org/10.3390/antibiotics15050501
Primary Topic
Antibiotic Resistance in Bacteria
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Long-Term Trends in Antimicrobial Resistance Among Gram-Negative Clinical Isolates at Mubarak Al-Kabeer Hospital, Kuwait (2007–2022)

Antibiotics
Antibiotic Resistance in Bacteria
article

Long-Term Trends in Antimicrobial Resistance Among Gram-Negative Clinical Isolates at Mubarak Al-Kabeer Hospital, Kuwait (2007–2022)

article en

Abstract

Objectives: To examine the long-term trends in antimicrobial resistance (AMR) among major Gram-negative pathogens including Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa collected from inpatient and outpatient specimens in Mubarak Al-Kabeer Hospital in Kuwait from 2007 to 2022. Methods: The antimicrobial resistance data for 39,200 non-duplicate Gram-negative isolates were collected from the Hospital Laboratory Information System (LIS). Retrospectively antibiotic susceptibility data were interpreted according to Clinical and Laboratory Standards Institute (CLSI) breakpoints with intermediate results classified as resistant. Logistic regression was applied to assess temporal trends in resistance for the following antibiotic cefotaxime, ceftazidime, ciprofloxacin, meropenem and imipenem. False discovery rate (FDR) correction was performed for multiple comparisons. Results: Third-generation cephalosporin resistance increased significantly, from 27% to 60% in Klebsiella pneumoniae and from 19% to 45% in Escherichia coli. Resistance to ciprofloxacin also increased, from 22% to 49% in K. pneumoniae and from 28% to 41% in E. coli. Notably, meropenem resistance in K. pneumoniae increased from 1% to 35% during the study period. Acinetobacter baumannii showed high resistance to most antibiotics (>75%), while colistin retained good activity (<2% resistance). By contrast, Pseudomonas aeruginosa showed relatively stable resistance patterns with only modest changes in susceptibility to key antibiotics. Conclusions: From 2007 to 2022, increasing resistance among major Gram-negative pathogens was observed, with cefotaxime resistance rising from 27% in 2007 to 60% in 2022 in Klebsiella pneumoniae and from 19% to 45% in Escherichia coli. Resistance to ciprofloxacin also increased over time. These findings highlight the increasing burden of antimicrobial resistance over time and emphasize the need for continued surveillance.

AntibioticsVol. 15(5)
Queen Mary University of London (GB), Mubarak Al Kabeer Hospital (KW), Kuwait Institute for Scientific Research (KW), Kuwait University (KW)
Good health and well-being
Openalex Percentile: Top 9%
Antibiotic Resistance in Bacteria
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.